Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Strober, B, Puig, L, Lebwohl, MG, Lakshminarasimhan, B, Khan, SA, Pillai, N, Kappelhoff, B, Weatherill, A, Warren, RB. HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Li, R, Hensley, PJ, Babjuk, M, Bukavina, L, Psutka, SP, Lerner, SP, O'Donnell, MA, Lotan, Y, Bree, KK, Redorta, JP, McConkey, DJ, Lee, BH, Mariappan, P, Mertens, LS, Soloway, MS, Svatek, RS, Tan, WS, Williams, SB, Gupta, S, Buckley, R, Kamat, AM. Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group. European Urology Oncology. 2025; 8(6)DOI:10.1016/j.euo.2025.08.003. PMID:41076366. IF:9.300(Q1/1D).

Zamora, V, Garin, O, Suárez, JF, Guedea, F, Pont, A, Pardo, Y, Goñi, A, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, Sancho, G, León, JPD, Macías, V, Gutiérrez, C, Castells, M, Ferrer, M. Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer. European Urology Open Science. 2025; 82DOI:10.1016/j.euros.2025.10.007. PMID:41311640. IF:4.500(Q1/2D).